Back

Activation of fibroblast growth factor 21 by Canagliflozin reduces high-fat diet associated obesity-related cardiac injury: a translational study from bench to bedside

31 August 2024 (07:55 - 08:50)
Organised by: Logo
Congress Presentation Part of: Nutrition and heart disease Obesity ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Ping-Yen Liu

National Cheng Kung University Hospital, Tainan (Taiwan)

8 More presentations in this session

Presentation thumbnail
Investigating the diverse role of ultra-processed foods on cardiometabolic multimorbidity: Highlights from the ATTICA prospective study (2002-2022)
Miss E. Damigou (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Cardioprotective potential of oleuropein, hydroxytyrosol, oleocanthal and their combination: unravelling complementary effects on acute myocardial infarction and metabolic syndrome.
Professor I. Andreadou (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Influence of chronic dietary nitrate on downstream atherogenic metabolites and the enteral microbiome
Doctor D. Messiha (Essen, DE)
Abstract Slides Video
Presentation thumbnail
Efficacy of diet with low glycemic index on coronary artery disease
Doctor J. Uzokov (Tashkent, UZ)
Abstract Slides Video
Presentation thumbnail
Mediterranean-type diet trajectories and 20-year cardiovascular disease incidence: the ATTICA study (2002-2022)
Miss E. Damigou (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Nutrition and heart disease

The Event

Event poster

ESC Congress 2024

31 August 2024 07:55 CET
You may be interested in
thumbnail
Congress Presentation
Canagliflozin improves hemodynamic parameters by impedance cardiography and left ventricular diastolic function in patients with type 2 diabetes mellitus
thumbnail
Congress Presentation
Effect of sodium-glucose type 2 cotransporter inhibitors on cardiac structure and function in patients with normal ejection fraction
thumbnail
Congress Presentation
Effect of SGLT2i on myocardial remodeling due to cardiorenal syndrome in rat model of heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources